Tecartus 0.4 - 2 x 10e8 cells dispersion for infusion
KTE-C19-104
Phase 1 small_molecule active
Quick answer
Tecartus 0.4 - 2 x 10e8 cells dispersion for infusion for Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) Relapsed/Refractory B-cell non-Hodgkin lymphoma (r/r NHL) is a Phase 1 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) Relapsed/Refractory B-cell non-Hodgkin lymphoma (r/r NHL)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active